Competition of SARS-CoV-2 variants on the pandemic transmission dynamics

被引:10
|
作者
Chen, Jiaqi [1 ]
Gu, Changgui [1 ]
Ruan, Zhongyuan [2 ]
Tang, Ming [3 ,4 ]
机构
[1] Univ Shanghai Sci & Technol, Business Sch, Dept Syst Sci, Shanghai 200093, Peoples R China
[2] Zhejiang Univ Technol, Inst Cyberspace Secur, Hangzhou 310023, Peoples R China
[3] East China Normal Univ, Sch Phys & Elect Sci, Shanghai 200241, Peoples R China
[4] East China Normal Univ, Shanghai Key Lab Multidimens Informat Proc, Shanghai 200241, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Competition between strains; Cross-immunity; Future variants; Periodicity; Resurgence of the previous strain; INFLUENZA; VACCINE;
D O I
10.1016/j.chaos.2023.113193
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
SARS-CoV-2 has produced various variants during its ongoing evolution. The competitive behavior driven by the co-transmission of these variants has influenced the pandemic transmission dynamics. Therefore, studying the impact of competition between SARS-CoV-2 variants on pandemic transmission dynamics is of considerable practical importance. In order to formalize the mechanism of competition between SARS-CoV-2 variants, we propose an epidemic model that takes into account the co-transmission of competing variants. The model focuses on how cross-immunity influences the transmission dynamics of SARS-CoV-2 through competitive mechanisms between strains. We found that inter-strain competition affects not only both the final size and the replacement time of the variants, but also the invasive behavior of new variants in the future. Due to the limited extent of cross-immunity in previous populations, we predict that the new strain may infect the largest number of individuals in China without control interventions. Moreover, we also observed the possibility of periodic outbreaks in the same lineage and the possibility of the resurgence of previous lineages. Without the invasion of a new variant, the previous variant (Delta variant) is projected to resurgence as early as 2023. However, its resurgence may be prevented by a new variant with a greater competitive advantage.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The Immune Response to SARS-CoV-2 and Variants of Concern
    Torbati, Elham
    Krause, Kurt L.
    Ussher, James E.
    VIRUSES-BASEL, 2021, 13 (10):
  • [22] Nanomedicine approaches against SARS-CoV-2 and variants
    Zhang, Han
    Liu, Yanbin
    Liu, Zhuang
    JOURNAL OF CONTROLLED RELEASE, 2024, 365 : 101 - 111
  • [23] SARS-CoV-2 variants, immune escape, and countermeasures
    Zhang, Yi
    Zhang, Haocheng
    Zhang, Wenhong
    FRONTIERS OF MEDICINE, 2022, 16 (02) : 196 - 207
  • [24] SARS-CoV-2 variants,immune escape,and countermeasures
    Yi Zhang
    Haocheng Zhang
    Wenhong Zhang
    Frontiers of Medicine, 2022, 16 (02) : 196 - 207
  • [25] SARS-CoV-2 Variants, Vaccines, and Host Immunity
    Mistry, Priyal
    Barmania, Fatima
    Mellet, Juanita
    Peta, Kimberly
    Strydom, Adele
    Viljoen, Ignatius M.
    James, William
    Gordon, Siamon
    Pepper, Michael S.
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [26] SARS-CoV-2 variants, immune escape, and countermeasures
    Yi Zhang
    Haocheng Zhang
    Wenhong Zhang
    Frontiers of Medicine, 2022, 16 : 196 - 207
  • [27] Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic
    Adriana Arellano-Llamas, Abril
    Vela-Ojeda, Jorge
    Hernandez-Caballero, Alvaro
    CURRENT ONCOLOGY REPORTS, 2022, 24 (02) : 209 - 213
  • [28] Hygiene in Anesthesia During the SARS-CoV-2 Pandemic
    Schulz-Stuebner, Sebastian
    Kunitz, Oliver
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2020, 55 (07/08): : 494 - 502
  • [29] Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic
    Abril Adriana Arellano-Llamas
    Jorge Vela-Ojeda
    Alvaro Hernandez-Caballero
    Current Oncology Reports, 2022, 24 : 209 - 213
  • [30] MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
    DeBarros, Kenya
    Khan, Mahfuz
    Coleman, Morgan
    Bond, Vincent C.
    Floyd, Virginia
    Gbodossou, Erick
    Diop, Amad
    Krumpe, Lauren R. H.
    O'Keefe, Barry R.
    Powell, Michael D.
    VIRUSES-BASEL, 2024, 16 (09):